Publications

home Publications

2017

13 Mitochondrial abnormalities related to the dysfunction of circulating endothelial colony-forming cells in moyamoya disease. Choi JW, Son SM, Mook-Jung I, Moon YJ, Lee JY, Wang KC, Kang HS, Phi JH, Choi SA, Chong S, Byun J, Kim SK. J Neurosurg. 2017 Dec 8:1-9. doi: 10.3171/2017.5.JNS17147. [Epub ahead of print] Link
12 Korean Brain Aging Study for the Early Diagnosis and Prediction of Alzheimer's Disease: Methodology and Baseline Sample Characteristics. Byun MS, Yi D, Lee JH, Choe YM, Sohn BK, Lee JY, Choi HJ, Baek H, Kim YK, Lee YS, Sohn CH, Mook-Jung I, Choi M, Lee YJ, Lee DW, Ryu SH, Kim SG, Kim JW, Woo JI, Lee DY; KBASE Research Group. Psychiatry Investig. 2017 Nov;14(6):851-863. doi: 10.4306/pi.2017.14.6.851. Epub 2017 Nov 7. Link
11 Low Serum Phosphorus Correlates with Cerebral A¥â Deposition in Cognitively Impaired Subjects: Results from the KBASE Study. Park JC, Han SH, Byun MS, Yi D, Lee JH, Park K, Lee DY, Mook-Jung I. Front Aging Neurosci. 2017 Nov 6;9:362. doi: 10.3389/fnagi.2017.00362. eCollection 2017. Link
10 SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease. Lee J, Kim Y, Liu T, Hwang YJ, Hyeon SJ, Im H, Lee K, Alvarez VE, McKee AC, Um SJ, Hur M, Mook-Jung I, Kowall NW, Ryu H. Aging Cell. 2017 Nov 11. doi: 10.1111/acel.12679. [Epub ahead of print] Link
0 9 TREM2 promotes A¥â phagocytosis by upregulating C/EBP¥á-dependent CD36 expression in microglia. Kim SM, Mun BR, Lee SJ, Joh Y, Lee HY, Ji KY, Choi HR, Lee EH, Kim EM, Jang JH, Song HW, Mook-Jung I, Choi WS, Kang HS. Sci Rep. 2017 Sep 11;7(1):11118. doi:10.1038/s41598-017-11634-x. Link
0 8 p62/SQSTM1/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis. Cha-Molstad H, Yu JE, Feng Z, Lee SH, Kim JG, Yang P, Han B, Sung KW, Yoo YD, Hwang J, McGuire T, Shim SM, Song HD, Ganipisetti S, Wang N, Jang JM, Lee MJ, Kim SJ, Lee KH, Hong JT, Ciechanover A, Mook-Jung I, Kim KP, Xie XQ, Kwon YT, Kim BY. Nat Commun. 2017 Jul 24;8(1):102. doi: 10.1038/s41467-017-00085-7. Link
0 7 Chemically treated plasma A¥â is a potential blood-based biomarker for screening cerebral amyloid deposition. Park JC, Han SH, Cho HJ, Byun MS, Yi D, Choe YM, Kang S, Jung ES, Won SJ, Kim EH, Kim YK, Lee DY, Mook-Jung I. Alzheimers Res Ther. 2017 Mar 22;9(1):20. doi: 10.1186/s13195-017-0248-8. Link
0 6 Increased acetylation of Peroxiredoxin1 by HDAC6 inhibition leads to recovery of A¥â-induced impaired axonal transport. Choi H, Kim HJ, Kim J, Kim S, Yang J, Lee W, Park Y, Hyeon SJ, Lee DS, Ryu H, Chung J, Mook-Jung I. Mol Neurodegener. 2017 Feb 28;12(1):23. doi: 10.1186/s13024-017-0164-1. Link
0 5 Annexin A1 restores A¥â1-42 -induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway. Park JC, Baik SH, Han SH, Cho HJ, Choi H, Kim HJ, Choi H, Lee W, Kim DK, Mook-Jung I. Aging Cell. 2017 Feb;16(1):149-161. doi: 10.1111/acel.12530. Link
0 4 PRAK mediates A¥â-RAGE driven autophagy pathway. Kim Y, Mook-Jung I. Oncotarget. 2017 Jan 24;8(4):5648-5649. doi: 10.18632/oncotarget.14544. Link